Researchers combined data from nearly 400 randomized trials that
assessed the effects of blood pressure drugs or of exercise on blood
pressure. They found that overall, each lowered blood pressure by
nearly 9 mmHg (millimeters of mercury) in patients with
hypertension.
"Exercise seems to achieve similar reductions in systolic blood
pressure as commonly used antihypertensive drugs among people with
high blood pressure," said the study's lead author Huseyin Naci, a
health policy researcher at the London School of Economics and
Political Science in the UK.
Naci and colleagues looked at 194 randomized controlled trials that
tested the impact of anti-hypertensive drugs in people with high
blood pressure or with elevated blood pressure that put them at risk
of hypertension, and 197 trials in similar groups that tested the
effect of exercise. They also included data from past analyses that
combined data from these kinds of trials.
All told, Naci's team had data for 10,461 volunteers in exercise
trials and 29,281 in medication trials.
None of the trials directly compared the effects of medication to
exercise. "We need direct head-to-head randomized controlled trials
comparing exercise and antihypertensive drugs to fully answer this
question," Naci said in an email.
When looking at all participants, including those with normal,
elevated and high blood pressure, the researchers found medications
to be more effective than exercise at lowering systolic blood
pressure – the "top" number in a blood pressure reading, which
indicates the pressure on blood vessel walls when the heart pumps.
But when the team focused just on the higher-risk group with
hypertension - defined in the study as systolic blood pressure of
140 mmHg or higher - they found exercise achieved results comparable
to medication: a drop of 8.96 mmHg, on average.
One of the study's limitations is that some participants in the
exercise trials were also on blood pressure medication, the authors
note in the British Journal of Sports Medicine.
[to top of second column] |
Naci and her colleagues also point out that they examined the
effects of different types of exercise, including cardio and
strength training, as well as different intensities, and found that
all types of exercise, and even low-intensity activity, may offer a
benefit.
The results warrant "renewed attention" to identifying effective
strategies for promoting exercise, they conclude.
The idea that exercise might be as good as medication at lowering
blood pressure isn't new, said Kerry Stewart of Johns Hopkins
Medicine in Baltimore, Maryland.
"The advantage of another study like this one is that it puts the
information out to the public, so maybe more physicians and patients
with hypertension will take notice of it and perhaps try exercise,"
he said. "Initially they would use exercise along with medications.
Hopefully if the exercise brought blood pressure down sufficiently
they could be weaned off some of their medications."
There is, however, a caveat to that message. "There is less of a
blood pressure lowering effect in people who are older," Stewart
explained. "It's about half the magnitude of the change this
analysis is showing."
Part of the problem in people 55 and older is that the arteries get
stiffer with age. "And that doesn't seem to get reversed much with
exercise," he said. "My guess is that a lot of people who are older
and have hypertension will probably be on some combination of
exercise and blood pressure lowering medications."
While exercise may not provide the same "bang for the buck" in terms
of lowering blood pressure in older people, plenty of other benefits
accrue to those who exercise, Stewart said, including weight loss,
lipid lowering and loss of visceral belly fat. "And those benefits
are tied to overall cardiovascular health," Stewart said.
SOURCE: https://bit.ly/2rVMu53 and https://bit.ly/2CD7XWF British
Journal of Sports Medicine, online December 18, 2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |